Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Sildenafil citrate

EU orphan designation number: EU/3/10/815   
Active ingredient: Sildenafil citrate
Indication: Treatment of postcardiotomy right ventricular failure
Sponsor: Pfizer Europe MA EEIG
Boulevard de la Plaine 17, 1050 Bruxelles, Belgique/ Pleinlaan 17, 1050 Brussel, België

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
3/12/2010 Orphan designation EMA/OD/068/10 (2010)8600 of 26/11/2010
22/10/2018 Transfer of orphan designation EMA/OD/068/10/T/01 (2018)6993 of 18/10/2018